Search form

You are here

Molnupiravir



WHO recommends Merck COVID-19 pill for non-severe, at-risk patients

  • The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after Covid-19 symptoms develop and then for the following five days
By AFP ·

Egypt approves Merck COVID-19 pill, says to be produced locally

By Reuters ·

Merck pill seen as ‘a huge advance’, raises hope of preventing COVID-19 deaths

By Reuters ·

Latest updates

How the adoption of electric vehicles is driving Saudi Arabia’s green agenda
Peshmerga fighter dies in Turkish strike in north Iraq
US sanctions fundraisers for extremist West Bank settlers who commit violence against Palestinians
Hindu-Muslim divisions sway voting in Indian district scarred by deadly riots
Pakistan urges climate change collaboration with UAE after record rains hit Gulf nation

Recommended

Saudi Arabia
Saudi Arabia and Armenia to forge ‘road map’ for diplomatic ties, FM Ararat Mirzoyan tells Arab News
Middle-East
Why displaced Syrians in Lebanon face an agonizing dilemma amid mounting hostility 
Middle-East
How the life and death of Walid Daqqah in an Israeli jail encapsulates Palestinian Prisoners’ Day

Search form

Print Edition
Read pdf version Subscribe now
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.